Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2812)
All Articles published online
|
Feb 21, 2008 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu JH, Guo XZ, Ren LN, Shao LC, Liu MP. KAI1 is a potential target for anti-metastasis in pancreatic cancer cells. World J Gastroenterol 2008; 14(7): 1126-1132 [PMID: 18286698 DOI: 10.3748/wjg.14.1126] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i7/1126.htm |
| Number | Citing Articles |
| 1 |
Arnav Bhattacharya, Anirudh Santhoshkumar, Hiroshi Kurahara, Sitaram Harihar. Metastasis Suppressor Genes in Pancreatic Cancer. Pancreas 2021; 50(7): 923 doi: 10.1097/MPA.0000000000001853
|
| 2 |
Chun-Yan Wu, Jun Yan, Yue-Feng Yang, Feng-Jun Xiao, Qing-Fang Li, Qun-Wei Zhang, Li-Sheng Wang, Xiao-Zhong Guo, Hua Wang. Overexpression of KAI1 induces autophagy and increases MiaPaCa-2 cell survival through the phosphorylation of extracellular signal-regulated kinases. Biochemical and Biophysical Research Communications 2011; 404(3): 802 doi: 10.1016/j.bbrc.2010.12.063
|
| 3 |
Sina Upheber, Alexandra Karle, Julia Miller, Stephanie Schlaugk, Eva Gross, Ute Reuning. Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology. Cellular Signalling 2015; 27(3): 652 doi: 10.1016/j.cellsig.2014.11.028
|
| 4 |
Jaeseob Lee, Moon-Sung Lee, Doo-Il Jeoung, Young-Myeong Kim, Hansoo Lee. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer. The Prostate 2017; 77(4): 350 doi: 10.1002/pros.23274
|
| 5 |
Zheng-Xiang Wang, Guang-Jing Zhang, Xiu-Fang Yang, Shi-Jun Feng, Shan-Shan Ji, Ya-Bin Qi. miRNA-633 and KAI1 as Potential Biomarkers of Malignant Melanoma
with Gastric Cancer. Combinatorial Chemistry & High Throughput Screening 2023; 26(5): 1001 doi: 10.2174/1386207325666220616125608
|
| 6 |
Andrew J. Sanders, Vladimir M. Saravolac, Malcolm D. Mason, Wen G. Jiang. Electric Cell-Substrate Impedance Sensing and Cancer Metastasis. Cancer Metastasis - Biology and Treatment 2012; 17: 41 doi: 10.1007/978-94-007-4927-6_3
|
| 7 |
Jaeseob Lee, Hee-Jung Byun, Moon-Sung Lee, Young-June Jin, Dooil Jeoung, Young-Myeong Kim, Hansoo Lee. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling. Oncotarget 2017; 8(1): 1641 doi: 10.18632/oncotarget.13767
|
| 8 |
Maria Fairbank, Pascal St-Pierre, Ivan R. Nabi. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase. Molecular BioSystems 2009; 5(8): 793 doi: 10.1039/b820820b
|
| 9 |
Daniel Grasso, Maria Noé Garcia, Juan L. Iovanna. Autophagy in Pancreatic Cancer. International Journal of Cell Biology 2012; 2012: 1 doi: 10.1155/2012/760498
|
| 10 |
Steven Christopher Smith, Dan Theodorescu. Learning therapeutic lessons from metastasis suppressor proteins. Nature Reviews Cancer 2009; 9(4): 253 doi: 10.1038/nrc2594
|
| 11 |
Yien Che Tsai, Allan M. Weissman. Dissecting the diverse functions of the metastasis suppressor CD82/KAI1. FEBS Letters 2011; 585(20): 3166 doi: 10.1016/j.febslet.2011.08.031
|
| 12 |
Mekel M. Richardson, Lisa K. Jennings, Xin A. Zhang. Tetraspanins and tumor progression. Clinical & Experimental Metastasis 2011; 28(3): 261 doi: 10.1007/s10585-010-9365-5
|
| 13 |
C. Y. Wu, X. Z. Guo, H. Y. Li. Hypoxia and Serum deprivation protected MiaPaCa-2 cells from KAI1-induced proliferation inhibition through autophagy pathway activation in solid tumors. Clinical and Translational Oncology 2015; 17(3): 201 doi: 10.1007/s12094-014-1211-9
|
| 14 |
Alexander N. Shoushtari, Russell Z. Szmulewitz, Carrie W. Rinker-Schaeffer. Metastasis-suppressor genes in clinical practice: lost in translation?. Nature Reviews Clinical Oncology 2011; 8(6): 333 doi: 10.1038/nrclinonc.2011.65
|
| 15 |
Moon‐Sung Lee, Jaeseob Lee, Young‐Myeong Kim, Hansoo Lee. The metastasis suppressor CD82/KAI1 represses the TGF‐β1 and Wnt signalings inducing epithelial‐to‐mesenchymal transition linked to invasiveness of prostate cancer cells. The Prostate 2019; 79(12): 1394 doi: 10.1002/pros.23837
|
| 16 |
Khulood M. Al-Khater, Sarah Almofty, Vijaya Ravinayagam, Noor Alrushaid, Suriya Rehman. Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer. Saudi Journal of Biological Sciences 2021; 28(6): 3391 doi: 10.1016/j.sjbs.2021.03.001
|
| 17 |
Jin Feng, Chao Huang, Jonathan D. Wren, Dao-Wen Wang, Jizhou Yan, Jiexin Zhang, Yujie Sun, Xiao Han, Xin A. Zhang. Tetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneity. Cancer and Metastasis Reviews 2015; 34(4): 619 doi: 10.1007/s10555-015-9585-x
|
| 18 |
Hui Yan, Xunda Ji, Jing Li, Lei Zhang, Peiquan Zhao. Overexpression of KAI1 inhibits retinoblastoma metastasis in vitro. Oncology Letters 2017; 13(2): 827 doi: 10.3892/ol.2016.5507
|
| 19 |
Vahideh Mohammadzadeh, Niloufar Rahiman, Seyedeh Maryam Hosseinikhah, Mahmood Barani, Abbas Rahdar, Mahmoud Reza Jaafari, Saman Sargazi, Mohammad Reza Zirak, Sadanand Pandey, Rahul Bhattacharjee, Ashish Kumar Gupta, Vijay Kumar Thakur, Belay Zeleke Sibuh, Piyush Kumar Gupta. Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update. Journal of Drug Delivery Science and Technology 2022; 73: 103459 doi: 10.1016/j.jddst.2022.103459
|
| 20 |
Zlatna Ruseva, Pamina Xenia Charlotte Geiger, Peter Hutzler, Matthias Kotzsch, Birgit Luber, Manfred Schmitt, Eva Gross, Ute Reuning. Tumor suppressor KAI1 affects integrin αvβ3-mediated ovarian cancer cell adhesion, motility, and proliferation. Experimental Cell Research 2009; 315(10): 1759 doi: 10.1016/j.yexcr.2009.01.007
|
| 21 |
Wei Wei, Hongyue Li, Na Li, Huihui Sun, Qiang Li, Xiaohong Shen. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin. Pancreatology 2013; 13(4): 384 doi: 10.1016/j.pan.2013.05.008
|
| 22 |
Bing-Hui Zhang, Wei Liu, Liang Li, Jian-Guang Lu, Ya-Nan Sun, De-Jun Jin, Xiu-Yu Xu. KAI1/CD82 and MRP1/CD9 Serve as Markers of Infiltration, Metastasis, and Prognosis in Laryngeal Squamous Cell Carcinomas. Asian Pacific Journal of Cancer Prevention 2013; 14(6): 3521 doi: 10.7314/APJCP.2013.14.6.3521
|
| 23 |
HONGYU LI, JIANJUN LI, XU LIU, JIANG CHEN, CHUNYAN WU, XIAOZHONG GUO. Effect of PTEN and KAI1 gene overexpression on the proliferation, metastasis and radiosensitivity of ASPC-1 pancreatic cancer cells under hypoxic conditions. Molecular Medicine Reports 2014; 10(4): 1973 doi: 10.3892/mmr.2014.2404
|
| 24 |
Julia Miller, Tobias F. Dreyer, Anne Sophie Bächer, Eva-Kathrin Sinner, Christine Heinrich, Anke Benge, Eva Gross, Sarah Preis, Jan Rother, Anthony Roberts, Gabriele Nelles, Tzenka Miteva, Ute Reuning. Differential tumor biological role of the tumor suppressor KAI1 and its splice variant in human breast cancer cells. Oncotarget 2018; 9(5): 6369 doi: 10.18632/oncotarget.23968
|
| 25 |
Shuo Wang, Jiang Chen, Xiao-Zhong Guo. <i>KAI1/CD82</i> gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers. World Journal of Gastrointestinal Oncology 2022; 14(8): 1388-1405 doi: 10.4251/wjgo.v14.i8.1388
|
| 26 |
Moon-Sung Lee, Hee-Jung Byun, Jaeseob Lee, Doo-Il Jeoung, Young-Myeong Kim, Hansoo Lee. Tetraspanin CD82 represses Sp1-mediated Snail expression and the resultant E-cadherin expression interrupts nuclear signaling of β-catenin by increasing its membrane localization. Cellular Signalling 2018; 52: 83 doi: 10.1016/j.cellsig.2018.09.001
|
| 27 |
Natalia Bailón-Moscoso, Juan Carlos Romero-Benavides, Patricia Ostrosky-Wegman. Development of anticancer drugs based on the hallmarks of tumor cells. Tumor Biology 2014; 35(5): 3981 doi: 10.1007/s13277-014-1649-y
|